Published in Eur J Neurol on August 01, 2012
Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. Neurology (2014) 2.25
Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology (2014) 2.15
Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease. Neurology (2015) 1.50
Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications. Environ Health Perspect (2013) 0.98
Meta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosis. Transl Neurodegener (2015) 0.87
Identifying the clusters within nonmotor manifestations in early Parkinson's disease by using unsupervised cluster analysis. PLoS One (2014) 0.85
Risk factors and prodromal markers and the development of Parkinson's disease. J Neurol (2013) 0.85
Individual and joint prevalence of three nonmotor symptoms of PD in the US general population. Mov Disord (2014) 0.81
Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker? Ann Clin Transl Neurol (2014) 0.81
The Concept of Prodromal Parkinson's Disease. J Parkinsons Dis (2015) 0.81
Advances in markers of prodromal Parkinson disease. Nat Rev Neurol (2016) 0.80
Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned. Front Aging Neurosci (2016) 0.78
Computer keyboard interaction as an indicator of early Parkinson's disease. Sci Rep (2016) 0.76
Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection. J Parkinsons Dis (2016) 0.76
Is there a need to redefine Parkinson's disease? J Neural Transm (Vienna) (2013) 0.76
Before the tremor: premotor symptoms of Parkinson's disease. Environ Health Perspect (2013) 0.75
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs. Alzheimers Res Ther (2016) 0.75
Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson's Disease. Front Aging Neurosci (2016) 0.75
Laboratory assessments in the course of Parkinson's disease: a clinician's perspective. J Neural Transm (Vienna) (2015) 0.75
Echogenicity of basal ganglia structures in different Huntington's disease phenotypes. J Neural Transm (Vienna) (2014) 0.75
Olfaction and incident Parkinson disease in US white and black older adults. Neurology (2017) 0.75
Benefit on motor and non-motor behavior in a specialized unit for Parkinson's disease. J Neural Transm (Vienna) (2017) 0.75
Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science (1968) 7.70
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Receptor sites for complement on certain human peripheral blood lymphocytes. J Immunol (1970) 4.09
Receptor sites of human monocytes for IgG. Int Arch Allergy Appl Immunol (1968) 4.07
Ascent of dinosaurs linked to an iridium anomaly at the Triassic-Jurassic boundary. Science (2002) 3.69
Crystal structure of the thermosome, the archaeal chaperonin and homolog of CCT. Cell (1998) 2.94
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains. J Biol Chem (1988) 2.74
Taxonomic relations between archaebacteria including 6 novel genera examined by cross hybridization of DNAs and 16S rRNAs. J Mol Evol (1982) 2.64
The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology (1969) 2.46
Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ (1996) 2.42
Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry (2002) 2.36
Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer (2005) 2.33
Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation (1997) 2.18
Interleukin-6 is a prognostic factor in multiple myeloma. Blood (1991) 2.16
Burden of atherosclerosis and risk of venous thromboembolism in patients with migraine. Neurology (2008) 2.16
Ferroglobus placidus gen. nov., sp. nov., A novel hyperthermophilic archaeum that oxidizes Fe2+ at neutral pH under anoxic conditions. Arch Microbiol (1996) 2.06
Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood (1992) 2.05
Operation for N2 small cell lung carcinoma. Ann Thorac Surg (1990) 2.04
Leaf-specific thionins of barley-a novel class of cell wall proteins toxic to plant-pathogenic fungi and possibly involved in the defence mechanism of plants. EMBO J (1988) 2.01
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood (1998) 1.90
Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer (2012) 1.90
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia (2006) 1.87
Presence of acetyl coenzyme A (CoA) carboxylase and propionyl-CoA carboxylase in autotrophic Crenarchaeota and indication for operation of a 3-hydroxypropionate cycle in autotrophic carbon fixation. J Bacteriol (1999) 1.86
The interaction of monocytes and macrophages with immunoglobulins and complement. Ser Haematol (1970) 1.82
Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology (2005) 1.77
Homocysteine in cerebral macroangiography and microangiopathy. Lancet (1999) 1.76
Juvenile asymmetric segmental spinal muscular atrophy (Hirayama's disease): three cases without evidence of "flexion myelopathy". Acta Neurol Scand (2001) 1.74
In vitro reactivity of human lymphocytes in uraemia--a comparison with the impairment of delayed hypersensitivity. Clin Exp Immunol (1969) 1.73
Total cholesterol and oxysterols: early markers for cognitive decline in elderly? Neurobiol Aging (2007) 1.73
Respiration of arsenate and selenate by hyperthermophilic archaea. Syst Appl Microbiol (2000) 1.70
Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry (2000) 1.70
Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke (2010) 1.69
Comparison of acceleration signals of simulated and real-world backward falls. Med Eng Phys (2010) 1.66
Reclassification of the crenarchael orders and families in accordance with 16S rRNA sequence data. Int J Syst Bacteriol (1997) 1.63
GBA-associated PD presents with nonmotor characteristics. Neurology (2011) 1.63
A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene (2006) 1.62
Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child (1991) 1.61
Revascularization in acute ischaemic stroke using the penumbra system: the first single center experience. Eur J Neurol (2009) 1.59
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. Eur J Neurol (2012) 1.57
Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry (1999) 1.57
Inhibition of capillary migration by antigen-antibody complexes. J Immunol (1969) 1.55
IgG subclass specificity of human monocyte receptor sites. Nature (1971) 1.55
Subacute dementia and imaging correlates in a case of Fahr's disease. J Neurol Neurosurg Psychiatry (2004) 1.53
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol (2001) 1.52
Comparison of stent free cell area and cerebral lesions after unprotected carotid artery stent placement. Eur J Vasc Endovasc Surg (2011) 1.51
The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol (2002) 1.51
Distal myasthenia gravis frequency and clinical course in a large prospective series. Acta Neurol Scand (2003) 1.50
Mobile stroke unit for diagnosis-based triage of persons with suspected stroke. Neurology (2012) 1.49
Organic solutes in hyperthermophilic archaea. Appl Environ Microbiol (1997) 1.49
PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene (2006) 1.48
Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology (2007) 1.48
Reference values and early determinants of intra-abdominal fat mass in primary school children. Horm Res Paediatr (2011) 1.46
Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation (1999) 1.46
Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology (2002) 1.46
Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Neurology (2008) 1.45
A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood. J Immunol (1968) 1.44
Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene (2009) 1.43
Towards the ecology of hyperthermophiles: biotopes, new isolation strategies and novel metabolic properties. FEMS Microbiol Rev (2000) 1.42
Subcutaneous apomorphine in Parkinson's disease. Lancet (1988) 1.41
Descriptive patient data as an explanation for the variation in average daily costs in intensive care. Anaesthesia (2001) 1.41
Nitric oxide induces apoptosis in mouse thymocytes. J Immunol (1995) 1.40
Detection of flexor tenosynovitis by magnetic resonance imaging: its relationship to diurnal variation of symptoms. J Rheumatol (1991) 1.40
Treatment of closed tibia shaft fractures: a survey from the 1997 Orthopaedic Trauma Association and Osteosynthesis International--Gerhard Küntscher Kreis meeting. J Orthop Trauma (2000) 1.40
Transient restless legs syndrome after spinal anesthesia: a prospective study. Neurology (2002) 1.39
[Spinal fibrocartilaginous embolism]. Nervenarzt (2005) 1.39
[Vascular parkinsonian syndrome]. Nervenarzt (2006) 1.39
Cortical and brain stem hyperexcitability in striatonigral degeneration. Mov Disord (1998) 1.38
Innate immune receptor expression in normal brain aging. Neuroscience (2007) 1.34
Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage (2000) 1.32
Influence of concurrent tasks on gait: a dual-task approach. Percept Mot Skills (1995) 1.31
Smartphone-based solutions for fall detection and prevention: the FARSEEING approach. Z Gerontol Geriatr (2012) 1.31
Thiobacillus ferrooxidans, a facultative hydrogen oxidizer. Appl Environ Microbiol (1990) 1.30
Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology (2003) 1.25
Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry (1998) 1.25
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies. Br J Haematol (1970) 1.23
Differential gene expression in peripheral blood of patients suffering from post-traumatic stress disorder. Mol Psychiatry (2007) 1.23
Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry (2004) 1.22
Levodopa in the treatment of Parkinson's disease. Eur J Neurol (2009) 1.21
ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Oncogene (2008) 1.21
In vivo observation of cell division of anaerobic hyperthermophiles by using a high-intensity dark-field microscope. J Bacteriol (1999) 1.20
The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol (2002) 1.20
Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (2004) 1.19
Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep (2002) 1.19
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients. J Neurol Neurosurg Psychiatry (1997) 1.17